维普中文期刊产品整合服务
28篇 您的检索式:作者名="Vespasiani"
    题名 作者 年代 出处 被引量
1Sexual outcomes after partial penectomy for penile cancer: results from a multi-institutional study显示文摘阴茎癌症是不平常的恶意。外科的治疗不可避免地正在支解。就 patients’ 上的强壮的影响而言;我们想要在部分 penectomy 以后评估性功能和满足的性生活。在这的病人学习(n = 25 ) 代表了从 2011 年 10 月为阴茎癌症出席了我们的机构并且被诊断并且对待到 2013 年 11 月的所有那些。所有病人经历了部分 penectomy 并且跟随起来(平均数:14 个月;变化:12-25 ) 。性 presurgical 基线用可勃起的机能障碍 15 的国际索引(IIEF-15 ) 被估计。每个病人的性结果被估计考虑四标准化了并且验证问询表。我们包括可勃起的功能分析了 IIEF-15 的工具和范围(IIEF-1-5 和 -15), 高潮的功能(IIEF-9 和 -10), 性欲望(IIEF-11 和 -12), 交际满足(IIEF-6-8 ) ,和全面满足(IIEF-13 和 -14) 。然后,我们也使用了勃起问询表(QEQ ) 的质量,治疗满足的可勃起的机能障碍库存(编辑) 并且自尊和关系(灼烧) 评估我们的病人的性功能和满足。最后的结果证明阴茎癌症导致几性并且 psychosexual 机能障碍。不过,为阴茎癌症经历部分 penectomy 的病人能在对在外科前在经期存在的那些稍微更低的层次维持性结果。Salvatore Sansalone Mauro Silvani Rosario Leonardi Giuseppe Vespasiani Valerio Iacovelli 2017Asian Journal of Andrology2017,19,1:6
2Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma显示文摘AIM:To evaluate if indolent B cell-non Hodgkin's lymphoma(B-NHL) and diffuse large B-cell lymphoma(DLBCL) in hepatitis C virus(HCV) positive patients could have different biological and clinical characteristics requiring different management strategies.METHODS:A group of 24 HCV related B-NHL patients(11 indolent,13 DLBCL) in whom the biological and clinical characteristics were described and confronted.Patients with DLBCL were managed with the standard of care of treatment.Patients with indolent HCV-related B-NHL were managed with antiviral treatment pegylated interferon plus ribavirin and their course observed.The outcomes of the different approaches were compared.RESULTS:Patients with DLBCL had a shorter duration of HCV infection and a higher prevalence of HCV genotype 1 compared to patients with indolent B-NHL in which HCV genotype 2 was the more frequent genotype.Five of the 9 patients with indolent HCV-relatedB-NHL treated with only antiviral therapy,achieved a complete response of their onco-haematological disease(55%).Seven of the 13 DLBCL patients treated with immunochemotheraphy obtained a complete response(54%).CONCLUSION:HCV genotypes and duration of HCV infection differed between B-NHL subtypes.Indolent lymphomas can be managed with antiviral treatment,while DLBCL is not affected by the HCV infection.Adriano M Pellicelli Massimo Marignani Valerio Zoli Mario Romano Aldo Morrone Lorenzo Nosotti Giuseppe Barbaro Antonio Picardi Umberto Vespasiani Gentilucci Daniele Remotti Cecilia D'Ambrosio Caterina Furlan Fabrizio Mecenate Ettore Mazzoni Ignazio Majolino Roberto Villani Arnaldo Andreoli Giorgio Barbarini 2011World Journal of Hepatology2011,3,11:4
3Non-cirrhotic portal hypertension with large regenerative nodules: A diagnostic challenge显示文摘Non-cirrhotic portal hypertension is a poorly understood condition characterized by portal hypertension in the absence of conventional hepatic cirrhosis and described in association with blood coagulation disorders, myeloproliferative and immunological diseases and with exposure to toxic drugs. Very recently, precise classification criteria have been proposed in order to define four distinct subcategories. The present case highlights how the clinical presentation, the confounding results from imaging studies, and the difficulties in the histological evaluation often render cases of non-cirrhotic portal hypertension a real diagnostic challenge. It also underscores the classification problems which can be faced once this diagnosis is performed. Indeed, the different subcategories proposed result from the prevalent subtypes in a spectrum of hepatic regenerative responses to a variety of injuries determining microcirculatory dis-turbances. More flexibility in classification should derive from this etiopathogenic background.Umberto Vespasiani Gentilucci Paolo Gallo Giuseppe Perrone Riccardo Del Vescovo Giovanni Galati Sandro Spataro Chiara Mazzarelli Adriano Pellicelli Antonella Afeltra Antonio Picardi 2011World Journal of Gastroenterology2011,17,20:2
4Incidentally detected renal cell carcinoma:role of ultrasonography显示文摘Porena M Vespasiani G Rosi P 1992J Clin Ultrasound1992,20,:1
5The antineoplastic role of bisphosphonates: ftom basic research to clinical evidence 显示文摘Santini D Vespasiani G U Vincenzi B 2003Ann Oncol2003,14,10:1
6Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD显示文摘Umberto Vespasiani‐Gentilucci Simone Carotti Giuseppe Perrone Chiara Mazzarelli Giovanni Galati Andrea Onetti‐Muda Antonio Picardi Sergio Morini 2015Liver Int2015,,2:1
7Matrix metalloproteinase‐10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair显示文摘Oihane Garcia‐Irigoyen Simone Carotti Maria U. Latasa Iker Uriarte Maite G. Fernández‐Barrena Maria Elizalde Raquel Urtasun Umberto Vespasiani‐Gentilucci Sergio Morini Jesús M. Banales William C. Parks Jose A. Rodriguez Josune Orbe Jesús Prieto Jose A. 2014Liver Int2014,,7:1
8The antineoplastic role of bisphosphonates: from basic research to clinical evidence显示文摘Santini D Vespasiani Gentilucci U Vincenzi B 2003Annals of Oncology2003,14,10:1
9Stones and urinary tract infections 显示文摘Miano R Germani S Vespasiani G 2007Urol Int2007,791,:1
10Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial显示文摘Savino M Di Stasi Antonella Giannantoni Arcangelo Giurioli Marco Valenti Germano Zampa Luigi Storti Francesco Attisani Andrea De Carolis Giovanni Capelli Giuseppe Vespasiani Robert L Stephen 2005Lancet Oncology2005,,1:1
11Evaluation of new computerized method for recording 7-day food intake in IDDM patients显示文摘Rivellese A A Ventura M M Vespasiani G 1991Diabet es Care1991,14,7:1
12Evaluation of new com-puterized method for recording 7-day food intake in IDDM patients显示文摘Rivellese A A Ventura MM Vespasiani G 1991Diabetes Care1991,14,7:1
13The antineoplastic role of bisphosphonates: from basic research to clinical evidence 显示文摘Santini D Vespasiani Gentilucci U Vincenzi B 2003Ann Oncol2003,14,10:1
14Technology for the Production of Electrical Strip at Acciai Special Terni显示文摘Vespasiani G Abbruzzese G 1998Technische Mitteilungen Krupp1998,,1:1
15Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease显示文摘Vespasiani Gentilucci U Perrone G Galati G 2006Histopathology2006,48,7:1
16Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial显示文摘Savino M Di Stasi Marco Valenti Cristian Verri Emanuele Liberati Arcangelo Giurioli Gioia Leprini Francesco Masedu Antonio R Ricci Francesco Micali Giuseppe Vespasiani 2011Lancet Oncology2011,,:1
17The antine- oplastic role of bisphosphonates: from basic research toclinical evi- dence 显示文摘Santini D Vespasiani Gentilucci U Vincenzi B 2003Annals of Oncology2003,14,10:1
18Evaluation of new computerized method for recording 7-day food intake in IDDM patients显示文摘RIVELLESE A A VENTURA M M VESPASIANI G 1991Diabetes Care1991,14,7:1
19Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study显示文摘经历了与 Egydio 在 2004 年 1 月和 2008 年 12 月之间的技术的阴茎弄直的 Peyronie 的疾病(PD ) 影响的 157 个病人的长期的结果被报导。仅仅稳定在外科以前的至少 6-12 月了的有 PD 的病人在这研究被注册。外科手术前的评价包括了动态回响颜色 Doppler 超声扫描评估阴茎畸形和山峰的度在 cavernosal 动脉和对有可勃起的功能 5 的国际索引(IIEF-5 ) 的管理的可勃起的功能的一个评价的收缩速度问询表。拉长的阴茎长度被记录 pre- 并且手术后地。外科的复杂并发症, cosmesis 和性功能,耐心的满足和手术后的可勃起的功能分别地在 3 个月, 1 年和 2 年手术后地被估计。在 20 个月的一个中部的后续时期以后(变化:12-24 月) ,我们发现了那温和剩余弯曲(12 %) 并且龟头感觉迟钝(3 %) 是部分不满的唯一的原因。接枝的拒绝都没被观察。所有病人恢复了他们的能力没有困难渗透。另外, 2.5   的 intraoperative 一般水准增加;厘米(变化:1.7-4.1  厘米) 在拉长的阴茎长度被记录,与从事穿透的性交的所有病人一起。在结论,这个过程为阴茎弯曲源于 PD 的修正代表一种安全、可再现的技术并且产出优秀化妆、功能的结果。Salvatore Sansalone Giulio Garaffa Rados Djinovic Stefano Pecoraro Mauro Silvani Guido Barbagli Alessandro Zucchi Giuseppe Vespasiani Carla Loreto 2011Asian Journal of Andrology2011,13,6:1
20Evaluation of new computerized method for recording 7-day food intake in IDDM patients显示文摘Rivellese AA Ventura MM Vespasiani G 1991Diabetes Care1991,14,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费